JLGPX
Price
$78.75
Change
-$0.37 (-0.47%)
Updated
Jun 5 closing price
Net Assets
108.58B
VIGAX
Price
$215.01
Change
-$1.54 (-0.71%)
Updated
Jun 5 closing price
Net Assets
293.94B
Interact to see
Advertisement

JLGPX vs VIGAX

Header iconJLGPX vs VIGAX Comparison
Open Charts JLGPX vs VIGAXBanner chart's image
JPMorgan Large Cap Growth R3
Price$78.75
Change-$0.37 (-0.47%)
VolumeN/A
Net Assets108.58B
Vanguard Growth Index Admiral
Price$215.01
Change-$1.54 (-0.71%)
VolumeN/A
Net Assets293.94B
JLGPX vs VIGAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JLGPX vs. VIGAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLGPX is a Buy and VIGAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 294B vs. JLGPX (109B). VIGAX pays higher dividends than JLGPX: VIGAX (0.46) vs JLGPX (0.00). JLGPX was incepted earlier than VIGAX: JLGPX (9 years) vs VIGAX (25 years). JLGPX (1.00) is less costly to investors than VIGAX (0.05). JLGPX is a more actively managed with annual turnover of: 32.00 vs. VIGAX (11.00). JLGPX has a lower initial minimum investment than VIGAX: JLGPX (0) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 16.49 vs. JLGPX (12.35). VIGAX return over 5 years is better than : 110.51 vs. JLGPX (69.25).
JLGPXVIGAXJLGPX / VIGAX
Total Expense Ratio0.940.051,880%
Annual Report Gross Expense Ratio1.000.052,000%
Fund Existence9 years25 years-
Gain YTD1.6052.52364%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets109B294B37%
Annual Yield % from dividends0.000.46-
Returns for 1 year12.3516.4975%
Returns for 3 years64.3772.3189%
Returns for 5 years69.25110.5163%
Returns for 10 yearsN/A291.37-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCY64.500.69
+1.08%
Mercury General Corp
RPRX33.760.32
+0.96%
Royalty Pharma plc
EXFY2.29-0.01
-0.22%
Expensify
ABCL2.37-0.06
-2.27%
AbCellera Biologics
SGBX1.00-0.14
-12.28%
Safe & Green Holdings Corp.